Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab

Janne B Kjersem; Tone Ikdahl; Tormod Guren; Eva Skovlund; Halfdan Sorbye; Julian Hamfjord; Per Pfeiffer; Bengt Glimelius; Christian Kersten; Hiroko Solvang; Kjell M Tveit; Elin H Kure

doi:10.1186/1471-2407-12-534

Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab

Janne B Kjersem
, Tone Ikdahl
, Tormod Guren
, Eva Skovlund
, Halfdan Sorbye
, Julian Hamfjord
, Per Pfeiffer
, Bengt Glimelius
, Christian Kersten
, Hiroko Solvang
, Kjell M Tveit
, Elin H Kure

KI, OUH, Research unit of Oncology (Odense)

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

ABSTRACT:

Original language	English
Journal	BMC Cancer
Volume	12
Pages (from-to)	534
ISSN	1471-2407
DOIs	https://doi.org/10.1186/1471-2407-12-534
Publication status	Published - 2012

Documents & Links

10.1186/1471-2407-12-534

SDU Link

Check access to the material in SDU Library's search engine

Fingerprint

Dive into the research topics of 'Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab'. Together they form a unique fingerprint.

Cite this

Kjersem, J. B., Ikdahl, T., Guren, T., Skovlund, E., Sorbye, H., Hamfjord, J., Pfeiffer, P., Glimelius, B., Kersten, C., Solvang, H., Tveit, K. M., & Kure, E. H. (2012). Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab. BMC Cancer, 12, 534. https://doi.org/10.1186/1471-2407-12-534

@article{d9538b309eb94ee7ad897354128e84d1,

title = "Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab",

abstract = "ABSTRACT:",

author = "Kjersem, \{Janne B\} and Tone Ikdahl and Tormod Guren and Eva Skovlund and Halfdan Sorbye and Julian Hamfjord and Per Pfeiffer and Bengt Glimelius and Christian Kersten and Hiroko Solvang and Tveit, \{Kjell M\} and Kure, \{Elin H\}",

year = "2012",

doi = "10.1186/1471-2407-12-534",

language = "English",

volume = "12",

pages = "534",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "BioMed Central",

}

Kjersem, JB, Ikdahl, T, Guren, T, Skovlund, E, Sorbye, H, Hamfjord, J, Pfeiffer, P, Glimelius, B, Kersten, C, Solvang, H, Tveit, KM & Kure, EH 2012, 'Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab', BMC Cancer, vol. 12, pp. 534. https://doi.org/10.1186/1471-2407-12-534

Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab. / Kjersem, Janne B; Ikdahl, Tone; Guren, Tormod et al.
In: BMC Cancer, Vol. 12, 2012, p. 534.

Research output: Contribution to journal › Journal article › Research › peer-review

TY - JOUR

T1 - Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab

AU - Kjersem, Janne B

AU - Ikdahl, Tone

AU - Guren, Tormod

AU - Skovlund, Eva

AU - Sorbye, Halfdan

AU - Hamfjord, Julian

AU - Pfeiffer, Per

AU - Glimelius, Bengt

AU - Kersten, Christian

AU - Solvang, Hiroko

AU - Tveit, Kjell M

AU - Kure, Elin H

PY - 2012

Y1 - 2012

N2 - ABSTRACT:

AB - ABSTRACT:

U2 - 10.1186/1471-2407-12-534

DO - 10.1186/1471-2407-12-534

M3 - Journal article

C2 - 23167843

SN - 1471-2407

VL - 12

SP - 534

JO - BMC Cancer

JF - BMC Cancer

ER -

Kjersem JB, Ikdahl T, Guren T, Skovlund E, Sorbye H, Hamfjord J et al. Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab. BMC Cancer. 2012;12:534. doi: 10.1186/1471-2407-12-534